ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•31 May 2026 10:20

KRX Foreign Holding Weekly (May 29th): Samsung Electronics, SK Hynix, Mobis, Samsung Elec (PREF)

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, Mobis, Samsung...

Logo
133 Views
Share
•25 Feb 2019 12:49

Smartkarma’s Week That Was in JP/​​​​​​​KR: Aruhi, Rakuten-Lyft, Ecopro BM, & English Annual Reports

KOSPI is up 9.4% and Nikkei is up 7.8% YTD. It has been an active first two months of 2019. Many stocks have retraced to the previous resistance...

Logo
653 Views
Share
•26 Dec 2018 07:42

Korean Stock Market Sectors 2018 Review & 2019 Outlook

In this report, we review the major sectors' performance in the Korean stock market in 2018 and also provide our outlook for them in 2019. We...

Logo
1.2k Views
Share
•10 Dec 2018 12:11

Smartkarma’s Week That Was in JP/​​​​​KR: Softbank, Nissan, & A Star Is Born in 2018 Rewind to 1937

The year is winding down and there are only three weeks left in 2018. The sentiment on the global stock markets has been turning down rapidly in...

Logo
556 Views
Share
•02 Dec 2018 21:29

The Smartkarma Week That Was in JP/KR: Nissan, J-Retail, Tesla/Panny, SK Rights, Biosimilars, Trade

This past week featured ~160 insights across the Smartkarma platform, with 35+ of them dealing with Japan, South Korea, and semiconductors/memory...

Logo
1.1k Views
Share
x